Schlieren, Switzerland

Stephan Utzinger

USPTO Granted Patents = 1 



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephan Utzinger

Introduction

Stephan Utzinger is a notable inventor based in Schlieren, Switzerland. He has made significant contributions to the fields of medicine, public health, immunology, molecular biology, and virology. His work focuses on developing innovative solutions to address health-related challenges, particularly those associated with allergies.

Latest Patents

Stephan Utzinger holds a patent for "CAT allergen conjugates and uses thereof." This invention provides compositions that include a virus-like particle (VLP) or a virus particle combined with at least one feline antigen, specifically targeting human allergens. The patent outlines methods for producing these compositions, which are designed to induce efficient immune responses, particularly antibody responses in mammals, including humans. The compositions are particularly useful in creating vaccines aimed at treating and preventing allergies to cat dander and other related allergens.

Career Highlights

Stephan Utzinger is associated with Cytos Biotechnology AG, a company known for its innovative approaches in biotechnology. His work at the company has been instrumental in advancing research and development in allergy treatments. His contributions have positioned him as a key figure in the field of immunology.

Collaborations

Stephan has collaborated with notable colleagues, including Martin F. Bachmann and Monika Bauer. These collaborations have further enhanced the impact of his research and innovations in the scientific community.

Conclusion

Stephan Utzinger's work exemplifies the intersection of innovation and health, particularly in addressing allergies through advanced biotechnology. His contributions continue to influence the development of effective treatments for allergy sufferers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…